Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.0764
Recommendation SELL
P/E 23.87
ROE 9.56 %
Capitalization 2,484,440,000 $
Dividend Yield 0.00 %
P/S 2.92
AII Position 498
P/E Position 342
ROE Position 407
Capitalization Position 622
Dividend Yield Position 597
Sales 851,100,000 $
10-Year Average Earnings 104,082,800 $
Shares Outstanding 76,000,000
Equity 1,088,900,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2019 6 851,100,000.00 $
2018 6 772,600,000.00 $
2017 6 769,900,000.00 $
2016 6 740,500,000.00 $
2015 6 722,500,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2019 6 4,600,000.00 $
2018 6 133,300,000.00 $
2017 6 17,400,000.00 $
2016 6 117,200,000.00 $
2015 6 79,800,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $

Equity:

YEAR MONTH AMOUNT
2019 6 1,088,900,000.00 $
2018 6 964,900,000.00 $
2017 6 768,000,000.00 $
2016 6 739,600,000.00 $
2015 6 661,700,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2019 6 76,000,000
2018 6 72,000,000
2017 6 68,800,000
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:



Google News for MYRIAD GENETICS:

GlobeNewswire (press release) - 2 hours ago
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ...
SAN FRANCISCO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have ...
WCX19 - 7 hours ago
We Analyzed Myriad Genetics, Inc. ($MYGN) – Here's What We ...
On its latest session, Myriad Genetics, Inc. ($MYGN) opened at 23.85, reaching a high of 24.8 and a low of 23.55 before closing at a price of ...
US Post News
Here's Why Myriad Genetics Shares Got Crushed Today
Shares of Myriad Genetics (NASDAQ:MYGN) fell over 42% today after the company reported fiscal first-quarter 2020 operating results.
Mitchell Messenger
Myriad Genetics (MYGN) Q1 Earnings and Revenues Miss Estimates
Myriad, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $186.30 million for the quarter ended ...
Antony Press
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds ...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Myriad Genetics (MYGN) Investors of Securities Class Action, Encourages ...
Motley Fool - 5 Nov 2019
Stock Recap:: Myriad Genetics (NASDAQ:MYGN)
Myriad Genetics (NASDAQ:MYGN) STOCK IN FOCUS: Overbought and Oversold levels. The stock has RSI reading of 38.2. RSI gives an ...
MarketWatch
Myriad Genetics, Inc. (MYGN) Provides Great Yield, Safety, And ...
Myriad Genetics, Inc., (MYGN) shares ended November 11, 2019 trading at $24.24 which saw uptrend of -16.62% since the beginning of 2019.
Barron's
Myriad Genetics, Inc. ($MYGN) Is Moving – Here's Why (2019-11-11)
On its latest session, Myriad Genetics, Inc. ($MYGN) opened at 23.45, reaching a high of 24.2 and a low of 23.12 before closing at a price of ...
Zacks.com
Independent Chairman John Henderson Just Bought Shares In ...
Investors who take an interest in Myriad Genetics, Inc. (NASDAQ:MYGN) should definitely note that the Independent Chairman, John ...
Nasdaq - 4 Nov 2019
Dynamic Growth Stocks: Evolent Health Inc. (EVH) and Myriad ...
Myriad Genetics Inc. (MYGN) shares on Monday's trading session, jumped 2.54 percent to see the stock exchange hands at $24.24 per unit.


Back